The immunogenicity of a novel A (H1N1) vaccine in HIV-infected children (Q30404630)

21 June 2017

title

The immunogenicity of a novel A (H1N1) vaccine in HIV-infected children (English)

1 reference

21 June 2017

Aisleen Bennett

5

0 references

Shamez N Ladhani

object named as

Shamez Ladhani

3

0 references

Paul Heath

object named as

Paul T Heath

12

0 references

Elizabeth Miller

13

object named as

Elizabeth Miller

1 reference

21 June 2017

author name string

Ifeanyichukwu O Okike

1

1 reference

21 June 2017

Chee Yung

2

1 reference

21 June 2017

Clarissa Oeser

4

1 reference

21 June 2017

Katja Doerholt

6

1 reference

21 June 2017

Sharon Storey

7

1 reference

21 June 2017

Sheila Donaghy

8

1 reference

21 June 2017

Nigel Butter

9

1 reference

21 June 2017

Katja Hoschler

10

1 reference

21 June 2017

Liz Sheasby

11

1 reference

21 June 2017

language of work or name

English

0 references

publication date

13 July 2011

1 reference

21 June 2017

1 reference

21 June 2017

volume

29

1 reference

21 June 2017

issue

38

1 reference

21 June 2017

page(s)

6636-6640

1 reference

Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study.

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

The underrecognized burden of influenza in young children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

The burden of influenza in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Safety and immunogenicity of influenza vaccination in individuals infected with HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Influenza surveillance in a cohort of HIV-infected children and adolescents immunized against seasonal influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Immunogenicity and tolerability of a trivalent virosomal influenza vaccine in a cohort of HIV-infected children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Humoral and Cellular Response to Influenza Vaccine in HIV-Infected Children With Full Viroimmunologic Response to Antiretroviral Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

HIV-1 viraemia and influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

T cell activation and human immunodeficiency virus replication after influenza immunization of infected children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Pneumococcal and influenza immunization and human immunodeficiency virus load in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Molecular analysis of an outbreak of influenza in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Influenza vaccination of HIV-1-positive and hiv-1-negative former intravenous drug users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Response to influenza virus vaccination in vertical HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Use of licensed vaccines for active immunization of the immunocompromised host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral load

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

Effect of influenza immunization on immunologic and virologic characteristics of pediatric patients infected with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

[Influenza vaccination in HIV infected children: immunologic and viral load changes]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.103

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2011.06.103

1 reference

21 June 2017

1 reference